spacer
spacer

PDBsum entry 1bda

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
1bda

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
265 a.a. *
Ligands
2Z0 ×2
Waters ×19
* Residue conservation analysis
PDB id:
1bda
Name: Hydrolase/hydrolase inhibitor
Title: Catalytic domain of human single chain tissue plasminogen activator in complex with dansyl-egr-cmk (dansyl-glu-gly-arg chloromethyl ketone)
Structure: Single chain tissue type plasminogen activator. Chain: a, b. Fragment: unp residues 298-562. Synonym: sc-tpa. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
Biol. unit: Dimer (from PQS)
Resolution:
3.35Å     R-factor:   not given    
Authors: W.Bode,M.Renatus,R.A.Engh
Key ref:
M.Renatus et al. (1997). Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA. EMBO J, 16, 4797-4805. PubMed id: 9305622 DOI: 10.1093/emboj/16.16.4797
Date:
07-May-98     Release date:   11-May-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P00750  (TPA_HUMAN) -  Tissue-type plasminogen activator from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
562 a.a.
265 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.4.21.68  - t-plasminogen activator.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specific cleavage of Arg-|-Val bond in plasminogen to form plasmin.

 

 
DOI no: 10.1093/emboj/16.16.4797 EMBO J 16:4797-4805 (1997)
PubMed id: 9305622  
 
 
Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
M.Renatus, R.A.Engh, M.T.Stubbs, R.Huber, S.Fischer, U.Kohnert, W.Bode.
 
  ABSTRACT  
 
Tissue type plasminogen activator (tPA) is the physiological initiator of fibrinolysis, activating plasminogen via highly specific proteolysis; plasmin then degrades fibrin with relatively broad specificity. Unlike other chymotrypsin family serine proteinases, tPA is proteolytically active in a single-chain form. This form is also preferred for therapeutic administration of tPA in cases of acute myocardial infarction. The proteolytic cleavage which activates most other chymotrypsin family serine proteinases increases the catalytic efficiency of tPA only 5- to 10-fold. The X-ray crystal structure of the catalytic domain of recombinant human single-chain tPA shows that Lys156 forms a salt bridge with Asp194, promoting an active conformation in the single-chain form. Comparisons with the structures of other serine proteinases that also possess Lys156, such as trypsin, factor Xa and human urokinase plasminogen activator (uPA), identify a set of secondary interactions which are required for Lys156 to fulfil this activating role. These findings help explain the anomalous single-chain activity of tPA and may suggest strategies for design of new therapeutic plasminogen activators.
 
  Selected figure(s)  
 
Figure 1.
Figure 1 Stereo ribbon plot of the catalytic domain of sc-tPA in 'standard' orientation. The inhibitor (dansyl-Glu-Gly-Arg-chloromethylketone) shown by green sticks is covalently bonded to Ser195 and His57 of the catalytic triad. Key sc-tPA residues are shown as yellow sticks: Asp102, His57 and Ser195 of the catalytic triad; Asp189 at the base of the S1 specificity pocket; and Asp194 and Lys156 which form a salt bridge in the activation pocket. The red ribbon shows the conformation of the N-terminal activation loop which includes the plasmin cleavage site. Some loops arranged around the active site are labelled: the mainly disordered 37 loop and the 110 loop to the east; the partially disordered 186 loop to the south-west is in proximity to the activation loop. The figure was made with SETOR (Evans, 1993).
Figure 2.
Figure 2 Stereo plot of the activation domain environment of sc-tPA involving residues of the activation pocket, the activation loop and Lys156. Lys156 (blue) stabilizes the active conformation of sc-tPA via formation of a salt bridge with Asp194 (red). The strength of this interaction is presumably increased by the concerted solvent shielding effect of the (red) activation loop and of the hydrophobic residues Ile16, Phe21 and His144 (yellow). Lysines 17 and 143, which were considered potential activators of sc-tPA (Wallén et al., 1983; Petersen et al., 1990) are also shown (blue). Residues His188, Arg186A and Asn186F of the 186 loop (yellow) are presumed to be responsible for the conformational stabilization of this loop.
 
  The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: EMBO J (1997, 16, 4797-4805) copyright 1997.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21406063 C.S.Craik, M.J.Page, and E.L.Madison (2011).
Proteases as therapeutics.
  Biochem J, 435, 1.  
21136135 J.Schaller, and S.S.Gerber (2011).
The plasmin-antiplasmin system: structural and functional aspects.
  Cell Mol Life Sci, 68, 785-801.  
19953505 D.Belorgey, P.Hägglöf, M.Onda, and D.A.Lomas (2010).
pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.
  Protein Sci, 19, 220-228.  
19666776 A.A.Komissarov, A.P.Mazar, K.Koenig, A.K.Kurdowska, and S.Idell (2009).
Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
  Am J Physiol Lung Cell Mol Physiol, 297, L568-L577.  
19180666 E.Di Cera (2009).
Serine proteases.
  IUBMB Life, 61, 510-515.  
19630791 J.A.Huntington (2009).
Slow thrombin is zymogen-like.
  J Thromb Haemost, 7, 159-164.  
15664988 M.Onda, D.Belorgey, L.K.Sharp, and D.A.Lomas (2005).
Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies.
  J Biol Chem, 280, 13735-13741.  
16162508 M.T.Murakami, and R.K.Arni (2005).
Thrombomodulin-independent activation of protein C and specificity of hemostatically active snake venom serine proteinases: crystal structures of native and inhibited Agkistrodon contortrix contortrix protein C activator.
  J Biol Chem, 280, 39309-39315.
PDB codes: 2aip 2aiq
16040602 P.Gál, V.Harmat, A.Kocsis, T.Bián, L.Barna, G.Ambrus, B.Végh, J.Balczer, R.B.Sim, G.Náray-Szabó, and P.Závodszky (2005).
A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations.
  J Biol Chem, 280, 33435-33444.
PDB code: 1zjk
15892855 W.Bode (2005).
The structure of thrombin, a chameleon-like proteinase.
  J Thromb Haemost, 3, 2379-2388.  
14594804 C.A.Ibarra, G.E.Blouse, T.D.Christian, and J.D.Shore (2004).
The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition.
  J Biol Chem, 279, 3643-3650.  
15291813 D.Belorgey, L.K.Sharp, D.C.Crowther, M.Onda, J.Johansson, and D.A.Lomas (2004).
Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB.
  Eur J Biochem, 271, 3360-3367.  
15211511 S.Terzyan, N.Wakeham, P.Zhai, K.Rodgers, and X.C.Zhang (2004).
Characterization of Lys-698-to-Met substitution in human plasminogen catalytic domain.
  Proteins, 56, 277-284.
PDB code: 1rjx
11880376 D.Belorgey, D.C.Crowther, R.Mahadeva, and D.A.Lomas (2002).
Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro.
  J Biol Chem, 277, 17367-17373.  
11854276 T.Oka, T.Hakoshima, M.Itakura, S.Yamamori, M.Takahashi, Y.Hashimoto, S.Shiosaka, and K.Kato (2002).
Role of loop structures of neuropsin in the activity of serine protease and regulated secretion.
  J Biol Chem, 277, 14724-14730.  
11420435 A.Pasternak, A.White, C.J.Jeffery, N.Medina, M.Cahoon, D.Ringe, and L.Hedstrom (2001).
The energetic cost of induced fit catalysis: Crystal structures of trypsinogen mutants with enhanced activity and inhibitor affinity.
  Protein Sci, 10, 1331-1342.
PDB codes: 1f5r 1f7z 1fy8 3tgk
11168406 R.Egelund, T.E.Petersen, and P.A.Andreasen (2001).
A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
  Eur J Biochem, 268, 673-685.  
10970872 H.M.Zhou, A.Nichols, P.Meda, and J.D.Vassalli (2000).
Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.
  EMBO J, 19, 4817-4826.  
10866798 S.Wang, G.L.Reed, and L.Hedstrom (2000).
Zymogen activation in the streptokinase-plasminogen complex. Ile1 is required for the formation of a functional active site.
  Eur J Biochem, 267, 3994-4001.  
11092938 Y.Tang, J.Zhang, L.Gui, C.Wu, R.Fan, W.Chang, and D.Liang (2000).
Crystallization and preliminary X-ray analysis of earthworm fibrinolytic enzyme component A from Eisenia fetida.
  Acta Crystallogr D Biol Crystallogr, 56, 1659-1661.  
10500112 C.P.Sommerhoff, W.Bode, P.J.Pereira, M.T.Stubbs, J.Stürzebecher, G.P.Piechottka, G.Matschiner, and A.Bergner (1999).
The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.
  Proc Natl Acad Sci U S A, 96, 10984-10991.  
10102985 H.Czapinska, and J.Otlewski (1999).
Structural and energetic determinants of the S1-site specificity in serine proteases.
  Eur J Biochem, 260, 571-595.  
10022823 H.Jing, K.J.Macon, D.Moore, L.J.DeLucas, J.E.Volanakis, and S.V.Narayana (1999).
Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D.
  EMBO J, 18, 804-814.
PDB code: 1fdp
10052945 J.Shobe, C.D.Dickinson, and W.Ruf (1999).
Regulation of the catalytic function of coagulation factor VIIa by a conformational linkage of surface residue Glu 154 to the active site.
  Biochemistry, 38, 2745-2751.  
10467148 K.P.Hopfner, A.Lang, A.Karcher, K.Sichler, E.Kopetzki, H.Brandstetter, R.Huber, W.Bode, and R.A.Engh (1999).
Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.
  Structure, 7, 989-996.
PDB code: 1rfn
10213631 S.Wang, G.L.Reed, and L.Hedstrom (1999).
Deletion of Ile1 changes the mechanism of streptokinase: evidence for the molecular sexuality hypothesis.
  Biochemistry, 38, 5232-5240.  
9819212 A.Pasternak, X.Liu, T.Y.Lin, and L.Hedstrom (1998).
Activating a zymogen without proteolytic processing: mutation of Lys15 and Asn194 activates trypsinogen.
  Biochemistry, 37, 16201-16210.  
  9568890 A.R.Khan, and M.N.James (1998).
Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.
  Protein Sci, 7, 815-836.  
9808033 C.T.Esmon, and T.Mather (1998).
Switching serine protease specificity.
  Nat Struct Biol, 5, 933-937.  
9783753 M.A.Parry, C.Fernandez-Catalan, A.Bergner, R.Huber, K.P.Hopfner, B.Schlott, K.H.Gührs, and W.Bode (1998).
The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action.
  Nat Struct Biol, 5, 917-923.
PDB code: 1bui
  9524060 M.T.Stubbs, M.Renatus, and W.Bode (1998).
An active zymogen: unravelling the mystery of tissue-type plasminogen activator.
  Biol Chem, 379, 95.  
9748324 T.Selwood, D.R.McCaslin, and N.M.Schechter (1998).
Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure.
  Biochemistry, 37, 13174-13183.  
9733510 X.Wang, X.Lin, J.A.Loy, J.Tang, and X.C.Zhang (1998).
Crystal structure of the catalytic domain of human plasmin complexed with streptokinase.
  Science, 281, 1662-1665.
PDB code: 1bml
9354616 M.Renatus, M.T.Stubbs, R.Huber, P.Bringmann, P.Donner, W.D.Schleuning, and W.Bode (1997).
Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage.
  Biochemistry, 36, 13483-13493.
PDB code: 1a5i
9434908 W.Bode, and M.Renatus (1997).
Tissue-type plasminogen activator: variants and crystal/solution structures demarcate structural determinants of function.
  Curr Opin Struct Biol, 7, 865-872.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer